← Open Payments lookup

CATHERINE MOORE: Open Payments

NPI 1952019465 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,392 in 81 payments from 16 companies in 2025. Trend: 2023 $850 · 2024 $881 · 2025 $1,392

Food & beverage: $1,392
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$249
Otsuka America Pharmaceutical, Inc.13$247
Vanda Pharmaceuticals Inc.10$175
Alkermes, Inc.10$159
Lundbeck LLC7$123
Takeda Pharmaceuticals U.S.A., Inc.6$97
Janssen Pharmaceuticals, Inc5$88
Neurocrine BioSciences, Inc.3$58
E.R. Squibb & Sons, L.L.C.3$46
ABBVIE INC.2$32

Products named: REXULTI, CAPLYTA, FANAPT, ARISTADA, TRINTELLIX, SPRAVATO, INGREZZA, COBENFY.

Industry payments across NJ — which companies pay providers there.